Together with other antibodies, p63 is also routinely used for tumor type determination, for example distinguishing squamous cell carcinoma from adenocarcinoma in lung biopsies, or urothelial carcinomas from renal cell carcinoma in tumors arising in the kidney as well as determining the tumor origin of metastases from unknown primary tumors. This evidence concerns the gene TP63 and neoplasm.